Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2008
11/27/2008US20080292828 Composition Comprising Various Proteorhodopsins and/or Bacteriorhodopsins and Use Thereof
11/27/2008US20080292735 Regulating alkaloids
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292602 T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
11/27/2008US20080292594 reduced expression of a sigma3 polypeptide; used to generate and stably propagate infectious subviral particle (ISVP); proliferative disorder
11/27/2008US20080292592 treating, preventing cancer using compositions including replication competent adenovirus; death domains; rapid and efficient spread through the tumor
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292576 Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE10224257B4 Verfahren zur Gewinnung eines Proteinisolats und einer Faserfraktion aus einer faser- und proteinhaltigen Ausgangssubstanz A process for obtaining a protein isolate and a fiber fraction from a fibrous and proteinaceous starting substance
11/27/2008DE102007024086A1 Nucleic acid coding for a signal peptide for producing recombinant proteins in secreted form has a restriction site in the vicinity of its 3' end
11/27/2008CA2690825A1 Fusion molecules and il-15 variants
11/27/2008CA2688724A1 Novel simian t-cell lymphotropic virus
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2687700A1 Cysteic acid derivatives of anti-viral peptides
11/27/2008CA2687632A1 Lyophilised antigen composition
11/27/2008CA2687627A1 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
11/27/2008CA2687605A1 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants
11/27/2008CA2687602A1 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
11/27/2008CA2687556A1 Crystal structures of neuropilin fragments and neuropilin-antibody complexes
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2687422A1 Composition and method for modulating plant root hair development
11/27/2008CA2685848A1 Plants having enhanced yield-related traits and a method for making the same
11/27/2008CA2684758A1 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
11/27/2008CA2684151A1 Method for producing mature vwf from vwf pro-peptide
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/27/2008CA2680661A1 Mutant reoviruses and methods of making and using
11/27/2008CA2676028A1 Methods of determining lethality of pathogens and malignancies involving replikin peak genes
11/27/2008CA2673477A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/27/2008CA2671934A1 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences
11/26/2008EP1995319A1 Bacillus licheniformis mutant host cell
11/26/2008EP1995318A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995317A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1995310A1 Novel methods for rescue of RNA viruses
11/26/2008EP1995256A1 EPHA2 T-cell epitope agonists and uses therefor
11/26/2008EP1995255A1 Truncated tau proteins
11/26/2008EP1994943A2 Chimeric vaccine antigens against classical swine fever virus
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994824A1 Chimeric non-human animal
11/26/2008EP1994411A2 Truncated proteins as cancer markers
11/26/2008EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1994153A2 Chimeric kunitz domains and their use
11/26/2008EP1994138A2 Process for preparing human g-csf
11/26/2008EP1994053A1 Soluble gp130 molecule variants useful as a medicament
11/26/2008EP1994052A1 Use of iex-1 for the treatment of glioma tumors
11/26/2008EP1994051A1 Gene encoding trehalose-6-phosphate phosphatase and use thereof
11/26/2008EP1994050A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof
11/26/2008EP1994049A1 Gene encoding acetolactate synthase and use thereof
11/26/2008EP1994048A2 Pegylated mutated clostridium botulinum toxin
11/26/2008EP1994047A2 Purification and use of streptococcus pneumoniae pili and pilus proteins
11/26/2008EP1993603A1 Hepatitis c virus non structural fusion protein
11/26/2008EP1993601A2 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
11/26/2008EP1993592A2 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
11/26/2008EP1993562A2 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
11/26/2008EP1841783A4 Second tc complex from xenorhabdus
11/26/2008EP1809662B1 Deamidated interferon-beta
11/26/2008EP1673388B1 Cxcl8 antagonists
11/26/2008EP1521770B1 Method for the production of protamine
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1396539B1 Human-type anti-blood coagulation factor viii antibody
11/26/2008EP1370572B1 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
11/26/2008EP1307478B1 Luxr gene from coryneform bacteria and a process for the production of l-amino acids
11/26/2008EP1276492B1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP1108042B1 Molecules designated b7l-1
11/26/2008EP1019537B1 Bioassay for thyroid stimulating antibodies
11/26/2008EP0957943B2 Matrix-free osteogenic devices, implants and methods of use thereof
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0820463B1 Igf-i purification process
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313306A Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas
11/26/2008CN101313069A Bioassays
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101312987A Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia
11/26/2008CN101312913A Material and a method for removing oxo-anions and metal cations from a liquid
11/26/2008CN101312745A Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on ghs-r1a as active ingredient
11/26/2008CN101312739A Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN100436583C Antifreeze gene from wild rice and its coded protein and application
11/26/2008CN100436581C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
11/26/2008CN100436579C Vitreoscilla hemoglobin gene and its uses
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 2916